Mycobacterium tuberculosis
, the causative agent of tuberculosis, has infected humans for millennia.
M. tuberculosis
is well adapted to establish infection, persist in the face of the host immune response and be transmitted to uninfected individuals. Its ability to complete this infection cycle depends on it both evading and taking advantage of host immune responses. The outcome of
M. tuberculosis
infection is often a state of equilibrium characterized by immunological control and bacterial persistence. Recent data have highlighted the diverse cell populations that respond to
M. tuberculosis
infection and the dynamic changes in the cellular and intracellular niches of
M. tuberculosis
during the course of infection.
M. tuberculosis
possesses an arsenal of protein and lipid effectors that influence macrophage functions and inflammatory responses; however, our understanding of the role that specific bacterial virulence factors play in the context of diverse cellular reservoirs and distinct infection stages is limited. In this Review, we discuss immune evasion and provocation by
M. tuberculosis
during its infection cycle and describe how a more detailed molecular understanding is crucial to enable the development of novel host-directed therapies, disease biomarkers and effective vaccines.